Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
Yannick Kaiser(Amsterdam University Medical Centers), Marc R. Dweck(University of Edinburgh), Marwa Daghem(University of Edinburgh), Pim van der Harst(Utrecht University), Kang H. Zheng(Twitter (United States)), Michelle C. Williams(University of Edinburgh), Nick S. Nurmohamed(George Washington University), Damini Dey(Cedars-Sinai Medical Center), Mhairi Doris(MACOM (United States)), Jacek Kwieciński(MACOM (United States)), Alastair J. Moss(MACOM (United States)), Mohammed N. Meah(University of Liverpool), David E. Newby(University of Edinburgh), Jeffrey Kroon(VIB-KU Leuven Center for Cancer Biology), Philip D Adamson(Christchurch Hospital), Erik S.G. Stroes(Amsterdam University Medical Centers), Evangelos Tzolos(University of Edinburgh)
Cited by 190
Related Papers
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
|European Heart Journal|2015|1.4k
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k
Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease
|Circulation Research|2017|1.2k